Garranzo, M., Segura, J., Beltrán, D., Rodríguez Gómez, J. M., Orgaz Martín, B., Arroyo Rodríguez, R., . . . Fernández Álvarez, L. (2023). A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines.

Garranzo, Marco, José Segura, David Beltrán, Juan Miguel Rodríguez Gómez, Belén Orgaz Martín, Rebeca Arroyo Rodríguez, Claudio Alba Rubio, e Leonides Fernández Álvarez. A Randomized Pilot Trial Assessing the Reduction of Gout Episodes in Hyperuricemic Patients By Oral Administration of Ligilactobacillus Salivarius CECT 30632, a Strain With the Ability to Degrade Purines. 2023.

Garranzo, Marco, et al. A Randomized Pilot Trial Assessing the Reduction of Gout Episodes in Hyperuricemic Patients By Oral Administration of Ligilactobacillus Salivarius CECT 30632, a Strain With the Ability to Degrade Purines. 2023.